Tau released from paired helical filaments with formic acid or guanidine is susceptible to calpain-mediated proteolysis

Journal of Neurochemistry

Volumn 69, Issue 4, 1997, Pages 1548-1558

  Yang, Liang Sheng ^a   Gordon Krajcer, Wanda ^a,b   Ksiezak Reding, Hanna ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Alzheimer's disease; Calpain; Formic acid; Guanidine; Paired helical filaments; Tau

Indexed keywords

CALPAIN; FORMIC ACID; GUANIDINE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

EID: 0030923581     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69041548.x     Document Type: Article

References (54)

1. Backstrom J. R., Miller C. A., and Tökes Z. A. (1992) Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. J. Neurochem. 58, 983-992.
2. Baki A., Tompa P., Alexa A., Molnar O., and Friedrich P. (1996) Autolysis parallels activation of μ-calpain. Biochem. J. 318, 897-901.
3. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., Seiteberger F., Grundke-Iqbal K., and Wisniewski H. M. (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477, 90-99.
4. Biernat J., Mandelkow E.-M., Schroter C., Lichtenberg-Kraag B., Steiner B., Berling B., Meyer H., Mercken M., Vandermeeren A., Goedert M., and Mandelkow E. (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 11, 1593-1597.
5. Billingsley M. L., Ellis C., Kincaid R. L., Martin J., Schmidt M., Lee V. M., and Trojanowski J. Q. (1994) Calcineurin immunoreactivity in Alzheimer's disease. Exp. Neurol. 126, 178-184.
6. Carmel G., Mager E. M., Binder L. I., and Kuret J. (1996) The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271, 32789-32795.
7. Delacourte A., Robitaille Y., Sergeant N., Buee L., Hof P. R., Wattez A., Laroche-Cholette A., Mathieu J., Chagnon P., and Gauvreau D. (1996) Specific pathological tau protein variants characterize Pick's disease. J. Neuropathol. Exp. Neurol. 55, 159-168.
8. Feany M. B., Ksiezak-Reding H., Liu W.-K., Vincent I., Yen S.-H., and Dickson D. W. (1995) Epitope expression and hyperphosphorylation of tau proteins in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol. 90, 37-43.
9. Flament S., Delacourte A., Verny M., Hauw J.-J., and Javoy-Agid F. (1991) Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol. 81, 591-596.
10. Goedert M., Spillantini M. G., Potier M. C., Ulrich J., and Crowther R. A. (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8, 393-399.
11. Goedert M., Spillantini M. G., Cairns N. J., and Crowther R. A. (1992) Tau proteins in Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168.
12. Goto K., Iwamoto T., and Kondo H. (1994) Localization of mRNAs for calpain and calpastatin in the adult rat brain by in situ hybridization histochemistry. Brain Res. 23, 40-46.
13. Greenberg S. G., Davies P., Schein J. D., and Binder L. I. (1992) Hydrofluoric acid-treated tauPHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267, 564-569.
14. Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M., and Binder L. I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913-4917.
15. Iqbal K., Zaidi T., Bancher C., and Grundke-Iqbal I. (1994) Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation. FEBS Lett. 349, 104-108.
16. Ivy G. O. (1992) Protease inhibition causes some manifestations of aging and Alzheimer's disease in rodent and primate brain. Ann. NY Acad. Sci. 674, 89-102.
17. Jicha G. A., Bowser R., Kazam I. G., and Davies P. (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48, 128-132.
18. Johnson G. V. W., Jope R. S., and Binder L. I. (1989) Proteolysis of tau by calpain. Biochem. Biophys. Res. Commun. 163, 1505-1511.
19. Johnson G. V. W., Litersky J. M., and Jope R. S. (1992) Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J. Neurochem. 56, 1630-1638.
20. Kayyali U. S., Zhang W., Yee A. G., Seidman J. G., and Potter H. (1997) Cytoskeletal changes in the brains of mice lacking calcineurin Aα. J. Neurochem. 68, 1668-1678.
21. Kenessey A. and Yen S. H. (1993) The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments. Brain Res. 629, 40-46.
22. Khachaturian Z. S. (1985) Diagnosis of Alzheimer's disease. Arch. Neurol. 42, 1097-1105.
23. Kidd M. (1963) Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197, 192-193.
24. Klunk W.E. and Pettegrew J.W. (1990) Alzheimer's β-amyloid protein is covalently modified when dissolved in formic acid. J. Neurochem. 54, 2050-2056.
25. Klunk W. E., Xu C.-J., and Pettegrew J. W. (1994) NMR identification of the formic acid-modified residue in Alzheimer's amyloid protein. J. Neurochem. 62, 349-354.
26. Kopke E., Tung Y.-C., Shaikh S., Iqbal K., and Grundke-Iqbal I. (1993) Microtubule-associated protein tau: abnormal phosphorylation prior to its assembly into paired helical filaments. J. Biol. Chem. 268, 24374-24384.
27. Kosik K. S., Orecchio L. D., Binder L. I., Trojanowski J., Lee V. M.-Y., and Lee G. (1988) Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1, 817-825.
28. Ksiezak-Reding H. and Wall J. S. (1994) Mass and physical dimensions of two distinct populations of paired helical filaments. Neurobiol. Aging 15, 11-19.
29. Ksiezak-Reding H. and Yen S.-H. (1991) Structural stability of paired helical filaments requires microtubule-binding domains of tau: a model for self-association. Neuron 6, 717-728.
30. Ksiezak-Reding H., Liu W.-K., and Yen S.-H. (1992) Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res. 597, 209-212.
31. Ksiezak-Reding H., Leibowitz R. L., Bowser R., and Davies P. (1995) Binding of Alz 50 depends on Phe8 in tau synthetic peptides and varies between native and denatured tau proteins. Brain Res. 697, 63-75.
32. Lee Y. C. and Wolff J. (1984) Calmodulin binds to both microtubule-associated protein 2 and tau proteins. J. Biol. Chem. 259, 1226-1230.
33. Leger J., Kempf M., Lee G., and Brandt R. (1997) Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. J. Biol. Chem. 272, 8441-8446.
34. Litersky J. M. and Johnson G. V. W. (1992) Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem. 267, 1563-1568.
35. Litersky J. M. and Johnson G. V. W. (1995) Phosphorylation of τ in situ: inhibition of calcium-dependent proteolysis. J. Neurochem. 65, 903-911.
36. Mattson M. P. (1994) Calcium and neuronal injury in Alzheimer's disease. Contributions of β-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann. NY Acad. Sci. 747, 50-76.
37. Mercken M., Grynspan F., and Nixon R. A. (1995) Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Lett. 368, 10-14.
38. 2+-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80-kDa form. J. Biol. Chem. 269, 27992-27995.
39. Molinari M., Anagli J., and Carafoli E. (1995) PEST sequences do not influence substrate susceptibility to calpain proteolysis. J. Biol. Chem. 270, 2032-2035.
40. Morishima M. and Ihara Y. (1994) Posttranslational modifications of tau in paired helical filaments. Dementia 5, 282-288.
41. Murayama S., Mori H., Ihara Y., and Tomonaga M. (1990) Immunocytochemical and ultrastructural studies of Pick's disease. Ann. Neurol. 27, 394-405.
42. Nixon R. A. (1989) Calcium-activated neutral proteinases as regulators of cellular function. Ann. NY Acad. Sci. 568, 198-208.
43. Ono T., Yamamoto J., Tashima K., Nakashima H., Okumura E., Yamada K., Hisanaga S., Kishimoto T., Miyakawa E., and Miyamoto E. (1995) Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease. Neurochem. Int. 26, 205-215.
44. Otvos L., Feiner L., Lang E., Szendrei G. I., Goedert M., and Lee V. M.-Y. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396-404. J. Neurosci. 39, 669-673.
45. Padilla R., Maccioni R. B., and Avila J. (1990) Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau. Mol. Cell. Biochem. 97, 35-41.
46. Saito K.-I., Elce J. S., Hamos J. E., and Nixon R. A. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA 90, 2628-2632.
47. Sandoval I. V. and Weber K. (1978) Calcium-induced inactivation of microtubule formation in brain extracts. Eur. J. Biochem. 92, 463-470.
48. Seubert P., Baudry M., Dudek S., and Lynch G. (1987) Calmodulin stimulates the degradation of brain spectrin by calpain. Synapse 1, 16-21.
49. Siman R., Ahdoot M., and Lynch G. (1987) Ontogeny, compartmentation and turnover of spectrin isoforms in rat central neurons. J. Neurosci. 7, 55-64.
50. Squier M. K. T., Miller A. C. K., Malkinson A. M., and Cohen J. J. (1994) Calpain activation in apoptosis. J. Cell. Physiol. 159, 229-237.
51. Trojanowski J. Q., Schmidt M. L., Shin R. W., Bramblett G. T., Rao D., and Lee V. M.-Y. (1993) Altered tau and neurofilament proteins in neurodegenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. 3, 45-54.
52. Wang K. K. W., Villalobo A., and Roufogalis B. D. (1989) Calmodulin-binding proteins as calpain substrates. Biochem. J. 262, 693-706.
53. Yang L.-S. and Ksiezak-Reding H. (1995) Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur. J. Biochem. 233, 9-17.
54. Yoshida H. and Ihara Y. (1993) τ in paired helical filaments is functionally distinct from fetal T: assembly incompetence of paired helical filaments. J. Neurochem. 61, 1183-1186.